Loading the company…
Loading the company…
Families: Peripheral arterial intervention.
All companies · Product and company coverage
In the last ten years FDA made 6 decisions for Spectranetics (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2017 (3). The latest was on 2025-03-13.
| Family | Decisions on record |
|---|---|
| Peripheral arterial intervention | 10 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-03-13 | 510(k) | K250385 | Turbo-Elite Laser Atherectomy Catheter |
| 2022-12-08 | 510(k) | K222837 | Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy Catheters |
| 2018-04-05 | 510(k) | K180694 | Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy Catheters |
| 2017-11-27 | 510(k) | K172687 | Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy Catheters |
| 2017-04-07 | 510(k) | K170059 | Spectranetics Turbo-Elite Laser Atherectomy Catheters |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Spectranetics.